{"id":57910,"date":"2024-02-27T18:06:46","date_gmt":"2024-02-27T18:06:46","guid":{"rendered":"https:\/\/medsname.com\/xalatan-eye-drop\/"},"modified":"2026-04-30T10:24:19","modified_gmt":"2026-04-30T10:24:19","slug":"xalatan-eye-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/xalatan-eye-drop\/","title":{"rendered":"Xalatan Eye Drop"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fffbe6;border-left:4px solid #f5a623;padding:14px 18px;margin:14px 0 22px;border-radius:6px;font-size:15px;line-height:1.55;\">\n<h3 style=\"margin:0 0 6px;font-size:17px;color:#8a6d3b;\">\u26a1 Quick Answer \u2014 What is Xalatan Eye Drop?<\/h3>\n<p style=\"margin:0;\">Xalatan Eye Drop is Latanoprost 0.005%, a once-daily prostaglandin eye drop that lowers eye pressure 25\u201333% in glaucoma. Apply one drop to each affected eye in the evening. Watch for iris darkening and eyelash growth.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong style=\"color:#1f3661;\">Why order from MedsBase?<\/strong> Sourced from a WHO-GMP certified manufacturer \u00b7 Discreet packaging \u00b7 Worldwide Shipping \u00b7 <a href=\"\/el\/reviews\/\" rel=\"noopener\">1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 \u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>Xalatan Eye Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our <a href=\"\/el\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a> \u2014 if it has not arrived after 20 business days we reship at no extra cost. Backed by 1,400+ verified customer reviews.<\/p>\n<h2>What is Xalatan Eye Drop?<\/h2>\n<p>Xalatan Eye Drop is manufactured by Pfizer and contains Latanoprost 0.005% as a sterile ophthalmic solution. Xalatan Eye Drop 0.005% is a prostaglandin F2&alpha; analog used to lower raised intra-ocular pressure (IOP) in open-angle glaucoma and ocular hypertension. It is one of the most potent IOP-lowering eye drops available \u2014 typical reduction is 25\u201333% from baseline. The 3 mL bottle contains benzalkonium chloride preservative \u2014 patients with significant sensitivity should consider preservative-free alternatives. <\/p>\n<h2>How Latanoprost Works<\/h2>\n<p>Latanoprost is a synthetic structural analogue of prostaglandin F2&alpha;. It binds the FP prostanoid receptor in the ciliary body, increasing uveoscleral outflow (the secondary drainage pathway for aqueous humour). Because it works on the outflow side of the equation rather than reducing aqueous production, it is additive with beta-blockers, alpha-2 agonists, and carbonic anhydrase inhibitors. The lash-growth effect comes from FP-receptor activation in the dermal papilla of the eyelash follicle, which prolongs anagen phase and thickens individual hair shafts.<\/p>\n<h2>\u0395\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>Open-angle glaucoma:<\/strong> first-line monotherapy for newly diagnosed primary open-angle glaucoma (POAG) per AAO Preferred Practice Pattern 2020.<\/li>\n<li><strong>Ocular hypertension:<\/strong> when IOP is consistently &gt; 21 mmHg with risk factors (thin cornea, family history, African or Hispanic ancestry).<\/li>\n<li><strong>Eyelash hypotrichosis<\/strong> (bimatoprost only \u2014 Latisse indication): cosmetic lash enhancement.<\/li>\n<li><strong>Add-on therapy<\/strong> when first-line agent does not reach target IOP \u2014 additive with timolol, brimonidine, dorzolamide.<\/li>\n<\/ul>\n<h2>Dosing &amp; Administration<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">\u0395\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">\u0394\u03cc\u03c3\u03b7<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">POAG \/ ocular hypertension<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 drop in affected eye(s) once daily, in the evening<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">If a dose is missed<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Skip and resume normal schedule next evening \u2014 do not double up<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">More than one drop?<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Adding a second drop does not increase IOP-lowering \u2014 it actually reduces efficacy by saturating receptors. Strictly one drop per eye.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">Multiple eye drops<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Wait at least 5 minutes between different eye-drop products to avoid washout<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Contact lenses<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Remove before instillation; reinsert 15 minutes after<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n<p><strong>Common (5\u201315%):<\/strong> ocular redness (conjunctival hyperaemia), eyelash thickening \/ lengthening \/ darkening, ocular pruritus, mild stinging on instillation, dry eye sensation.<\/p>\n<p><strong>Cosmetically notable:<\/strong><\/p>\n<ul>\n<li><strong>Iris pigmentation<\/strong> (1\u20132% over months to years): permanent darkening of light-coloured (blue, green, hazel) irises by stimulating iris stromal melanocytes. Brown irises usually unaffected. Lashes and periorbital skin may also darken.<\/li>\n<li><strong>Periorbital fat atrophy \/ prostaglandin-associated periorbitopathy (PAP):<\/strong> deepening of the upper-lid sulcus, eyelid ptosis, enophthalmos. Most reported with bimatoprost &gt; travoprost &gt; latanoprost. Usually reversible 3\u20136 months after stopping.<\/li>\n<li><strong>Periorbital skin pigmentation:<\/strong> reversible darkening of lid\/peri-orbital skin from drug runoff.<\/li>\n<\/ul>\n<p><strong>\u039b\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u03c3\u03c5\u03c7\u03bd\u03ad\u03c2:<\/strong> cystoid macular oedema (CME) \u2014 especially in pseudophakic eyes or those with macular pathology; uveitis re-activation in patients with a history of uveitis; reactivation of herpes simplex keratitis.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">Iris pigmentation is permanent.<\/strong> Patients with blue, green, or hazel eyes who use a prostaglandin analog long-term may develop irreversible darkening of the iris (especially asymmetric if treating only one eye). Discuss this risk before starting if cosmetic concern matters to you.<\/div>\n<h2>Warnings &amp; Contraindications<\/h2>\n<ul>\n<li><strong>Active uveitis or iritis<\/strong> \u2014 relative contraindication; can re-activate intraocular inflammation<\/li>\n<li><strong>Pseudophakic eyes with torn posterior capsule, aphakia, or known macular oedema risk<\/strong> \u2014 increased risk of cystoid macular oedema<\/li>\n<li><strong>Active herpes simplex keratitis<\/strong> \u2014 may reactivate viral disease<\/li>\n<li><strong>Pregnancy \/ breastfeeding<\/strong> \u2014 Category C; avoid unless benefit clearly outweighs risk (theoretical uterine smooth-muscle activity)<\/li>\n<li><strong>Children &lt; 16 years<\/strong> \u2014 safety not established for cosmetic lash use<\/li>\n<\/ul>\n<h2>\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n<p>Store at room temperature (15\u201325\u00b0C \/ 59\u201377\u00b0F) away from direct sunlight. Do not freeze. Discard 28 days after first opening. Keep the bottle tightly capped between uses to prevent contamination.<\/p>\n<p><!-- medsbase-intent-fill-2026-04-29 --><\/p>\n<h2>Xalatan vs generic latanoprost \u2014 should you switch?<\/h2>\n<p>Xalatan is the original branded latanoprost 0.005% from Pfizer (FDA-approved 1996). Generic latanoprost has been available since 2011, manufactured by multiple companies. Both contain the same active ingredient at the same concentration. The clinical question is whether the difference between them justifies the price difference.<\/p>\n<table>\n<thead>\n<tr>\n<th>\u03a7\u03b1\u03c1\u03b1\u03ba\u03c4\u03b7\u03c1\u03b9\u03c3\u03c4\u03b9\u03ba\u03cc<\/th>\n<th>Xalatan (Pfizer)<\/th>\n<th>Generic latanoprost<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Active ingredient + concentration<\/td>\n<td>Latanoprost 0.005%<\/td>\n<td>Latanoprost 0.005%<\/td>\n<\/tr>\n<tr>\n<td>IOP reduction (clinical trials)<\/td>\n<td>25\u201333%<\/td>\n<td>25\u201333% (FDA bioequivalence)<\/td>\n<\/tr>\n<tr>\n<td>Preservative<\/td>\n<td>Benzalkonium chloride (BAK) 0.02%<\/td>\n<td>Usually BAK; some preservative-free generics available<\/td>\n<\/tr>\n<tr>\n<td>Refrigeration before opening<\/td>\n<td>Yes (2\u20138 \u00b0C)<\/td>\n<td>Most generics: yes; some require ambient<\/td>\n<\/tr>\n<tr>\n<td>Stability after opening<\/td>\n<td>4 weeks at room temperature<\/td>\n<td>4 weeks at room temperature<\/td>\n<\/tr>\n<tr>\n<td>Cost per 2.5 ml bottle<\/td>\n<td>Higher (branded)<\/td>\n<td>~30\u201360% lower<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Most patients can switch from Xalatan to generic latanoprost without losing IOP control. The main exception is patients who developed BAK-related ocular surface disease on Xalatan and need a preservative-free formulation \u2014 those are limited to specific generics (Monoprost, Lacoma PF) or need to switch to a different prostaglandin.<\/p>\n<h2>Xalatan vs other prostaglandin eye drops<\/h2>\n<table>\n<thead>\n<tr>\n<th>Drop<\/th>\n<th>Active<\/th>\n<th>IOP reduction<\/th>\n<th>Iris pigmentation risk<\/th>\n<th>Periorbital fat atrophy (PAP)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Xalatan \/ latanoprost<\/strong><\/td>\n<td>Latanoprost 0.005%<\/td>\n<td>25\u201333%<\/td>\n<td>Significant in light-hued eyes<\/td>\n<td>Less than bimatoprost<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/el\/lumigan-eye-drop\/\">Lumigan \/ bimatoprost<\/a><\/td>\n<td>Bimatoprost 0.01% \/ 0.03%<\/td>\n<td>30\u201335% (the strongest IOP reducer of the class)<\/td>\n<td>Significant<\/td>\n<td>Most reported with this molecule<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/el\/travatan-eye-drop\/\">Travatan \/ travoprost<\/a><\/td>\n<td>Travoprost 0.004%<\/td>\n<td>27\u201332%<\/td>\n<td>Significant<\/td>\n<td>Reported<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/el\/lacoma-pf-eye-drop\/\">Lacoma PF<\/a><\/td>\n<td>Latanoprost 0.005% (preservative-free)<\/td>\n<td>25\u201333%<\/td>\n<td>Same as Xalatan<\/td>\n<td>Same<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>What about Xalatan and lash growth?<\/h3>\n<p>Latanoprost was the first prostaglandin shown to thicken, lengthen and darken eyelashes \u2014 an unintended cosmetic effect that led directly to the development of the bimatoprost-based <a href=\"\/el\/careprost-eye-drops\/\">Careprost \/ Latisse<\/a> for lash hypotrichosis. With Xalatan, lashes typically thicken over 3\u20136 months and revert when the drop is stopped. This effect is harmless when expected \u2014 but periocular skin can also darken slightly, which is harder to reverse.<\/p>\n<h3>What does Xalatan cost vs generics?<\/h3>\n<p>Branded Xalatan from Pfizer carries a premium of roughly 2\u20133\u00d7 over generic latanoprost. We supply both \u2014 the WHO-GMP certified generic latanoprost is the same molecule at the same concentration with documented bioequivalence. See the <a href=\"\/el\/eye-care\/\">Eye Care category<\/a> for the full prostaglandin family.<\/p>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3>How long until I see results from Xalatan Eye Drop?<\/h3>\n<p>For glaucoma, IOP reduction begins within 4 hours of the first dose with maximum effect at 8\u201312 hours; steady-state IOP is reached at 4 weeks. For lash growth (bimatoprost), visible thickening at 4 weeks and full lash growth at 16 weeks.<\/p>\n<h3>What if I forget a dose?<\/h3>\n<p>Skip the missed dose and resume your normal once-nightly schedule. Do not double up \u2014 using two drops at once actually reduces efficacy because of receptor saturation.<\/p>\n<h3>Why does Latanoprost darken eye colour?<\/h3>\n<p>Latanoprost activates the FP prostanoid receptor on iris stromal melanocytes, stimulating melanin production. Lighter irises (blue, green, hazel) contain less baseline melanin and so show change more readily. The effect is permanent and may be asymmetric if only one eye is treated.<\/p>\n<h3>Can I use Xalatan Eye Drop if I wear contact lenses?<\/h3>\n<p>Yes, but remove your contacts before instillation and wait 15 minutes before re-inserting. The benzalkonium chloride preservative can be absorbed by soft lenses and cause irritation.<\/p>\n<h3>Is Xalatan Eye Drop safe in pregnancy?<\/h3>\n<p>Category C. Theoretical concerns about prostaglandin effects on uterine smooth muscle. Discuss with your ophthalmologist \u2014 most clinicians switch to a beta-blocker or brimonidine during pregnancy, or pause cosmetic lash use entirely.<\/p>\n<h3>What happens if I stop using Xalatan Eye Drop?<\/h3>\n<p>For glaucoma, IOP returns to baseline within 4 weeks of stopping. For cosmetic lash use, lashes return to their pre-treatment length and density 4\u20138 weeks after stopping. Iris darkening, however, is permanent.<\/p>\n<h3>Can I use Xalatan Eye Drop on my lower lashes?<\/h3>\n<p>No. The product is approved for upper-lash-line application only. Lower-lash application creates excessive runoff onto the cheek, increasing the risk of unwanted hair growth on skin and skin pigmentation changes.<\/p>\n<h3>Does Xalatan Eye Drop cause periorbital changes?<\/h3>\n<p>Yes \u2014 prostaglandin-associated periorbitopathy (PAP) describes the syndrome of deepening upper-lid sulcus, ptosis, and enophthalmos seen in 5\u201325% of long-term users. Bimatoprost has the highest reported rate; latanoprost the lowest. Usually reversible 3\u20136 months after stopping.<\/p>\n<h3>Can Xalatan Eye Drop be combined with other glaucoma drops?<\/h3>\n<p>Yes \u2014 prostaglandin analogs are additive with beta-blockers, alpha-2 agonists, and carbonic anhydrase inhibitors because they target the outflow side. Wait 5 minutes between different drops. Fixed combinations such as bimatoprost+timolol exist for adherence.<\/p>\n<h3>What is the difference between Latanoprost and other prostaglandins?<\/h3>\n<p>All three (latanoprost, travoprost, bimatoprost) lower IOP 25\u201333%. Latanoprost has the gentlest side-effect profile. Travoprost has a slightly higher response rate. Bimatoprost is the most potent for both IOP and lash growth, but with the highest rate of conjunctival hyperaemia and PAP.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>Other Eye-Care Medications<\/h3>\n<p>Customers viewing this product also consider these alternatives in our <a href=\"\/el\/eye-care\/\">\u03a6\u03c1\u03bf\u03bd\u03c4\u03af\u03b4\u03b1 \u039c\u03b1\u03c4\u03b9\u03ce\u03bd<\/a> range:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/xalatan-eye-drop\/\">Xalatan Eye Drop (latanoprost)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/azopt-eye-drops\/\">Azopt Eye Drops (brinzolamide)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/alphagan-p-drop\/\">Alphagan P Drop (brimonidine)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/iotim-eye-drops\/\">Iotim Eye Drops (timolol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/careprost-eye-drops\/\">Careprost (bimatoprost)<\/a><\/li>\n<\/ul>\n<h3>\u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0391\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u0395\u03c5\u03b8\u03cd\u03bd\u03b7\u03c2<\/h3>\n<p style=\"font-size:13px;color:#555;\">The information on this page is for educational purposes only and is not a substitute for medical advice from a qualified ophthalmologist or optometrist. Eye conditions can rapidly threaten sight \u2014 sudden vision loss, severe pain, or trauma is an ophthalmology emergency. Always consult an eye-care professional before starting, stopping, or changing any treatment.<\/p>","protected":false},"excerpt":{"rendered":"<p>Xalatan (latanoprost 0.005%) \u2014 Pfizer original prostaglandin analogue. Once-daily eye drop, first-line IOP lowering for open-angle glaucoma. Bedtime instillation.<\/p>","protected":false},"featured_media":57911,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3343,3342],"product_tag":[4381,4382,4383],"class_list":{"0":"post-57910","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-eye-care","8":"product_cat-general-health","9":"product_tag-latanoprost","10":"product_tag-xalatan","11":"product_tag-xalatan-eye-drop","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/57910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=57910"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/57911"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=57910"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=57910"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=57910"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=57910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}